Scancell picks PharmaJet’s needle-free injection systems to deliver COVID-19 vaccine candidates

PharmaJet announced today that its partner, Scancell, chose its needle-free injection platform to administer its COVID-19 vaccine candidates.

Scancell selected Golden, Colorado-based PharmaJet’s devices to administer two SARS-CoV-2 DNA-based vaccine candidates, SCOV1 and SCOV2. The vaccines will be exclusively administered using the PharmaJet Tropis and PharmaJet Stratis needle-free injection systems.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0